Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers

SIMPLE SUMMARY: Patients with head and neck cancers may suffer from cancer-associated thromboembolism and direct oral anticoagulants (DOACs) are a potential new therapeutic option. We aimed to determine the clinical impact of DOACs compared with traditional anticoagulants on the survival of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chien-Lin, Chen, Wei-Shan, Wee, Yinshen, Wang, Ching-Shuen, Chen, Wei-Chih, Chiu, Tai-Jan, Wang, Yu-Ming, Wu, Ching-Nung, Yang, Yao-Hsu, Luo, Sheng-Dean, Wu, Shao-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833638/
https://www.ncbi.nlm.nih.gov/pubmed/35158969
http://dx.doi.org/10.3390/cancers14030703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833638/
https://www.ncbi.nlm.nih.gov/pubmed/35158969
http://dx.doi.org/10.3390/cancers14030703

Ejemplares similares